CEO: | Juho Jalkanen |
CFO: | Yrjö E K Wichmann |
Chairman: | Tuomo Pätsi |
Director: | Markku Jalkanen |
Independent Non-Executive Director: | John Poulos |
Non-Executive Dir: | Christine Roth , Colin Bond , Marie-Louise Fjällskog |
Address: | Joukahaisenkatu 6, Turku, Finland, FI-20520 |
Phone: | +358 2 469 5151 |
Fax: | +358 2 469 5152 |
Website: | http://www.faronpharmaceuticals.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | FI4000153309 |
Currency | UK Pounds |
Share Price | 252.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 262.50p |
52 Week Low | 92.50p |
Volume | 0 |
Shares Issued | 111.60m |
Market Cap | £281.79m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 1 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
0 @ 0.000p |
CFO | Yrjö E K Wichmann |
CEO | Juho Jalkanen |
Chair | Tuomo Pätsi |
You are here: research